128 results
6-K
EX-99.1
QNTM
Quantum BioPharma Ltd
7 Oct 24
Current report (foreign)
7:32am
in the development of science-driven solutions designed to enhance individual health and recovery processes, marking a new era in the support of responsible
6-K
EX-99.1
QNTM
Quantum BioPharma Ltd
30 Aug 24
Current report (foreign)
9:46am
, marking a new era in the support of responsible alcohol consumption.
About Quantum BioPharma Ltd.
Quantum BioPharma Ltd. is a biopharmaceutical company
6-K
EX-4.1
QNTM
Quantum BioPharma Ltd
26 Aug 24
Current report (foreign)
6:04pm
to the disadvantage of a party merely because that party was responsible for the preparation of this Agreement or the inclusion of the provision … will at its sole cost and risk be responsible for all actions required to Commercialize the Licensed IP including but not limited to any further development
6-K
EX-4.4
QNTM
Quantum BioPharma Ltd
26 Aug 24
Current report (foreign)
6:04pm
will not be responsible for any loss occasioned by its exercise of such rights or by failure to exercise the same within the time limited for the exercise thereof other … of such securities may at any time have, but the Secured Party shall not be responsible for any loss occasioned by the exercise of any of such rights
6-K/A
EX-99.1
QNTM
Quantum BioPharma Ltd
19 Aug 24
Condensed consolidated interim financial statements
5:18pm
decision maker is the CEO who is responsible for allocating resources, assessing the performance of the reportable segment and making key strategic … milestones are met. Furthermore, the Company is also responsible to pay revenue milestone payments and royalties if revenue milestones from commercial sales
6-K/A
EX-99.2
pg55k6 x2q
19 Aug 24
Condensed consolidated interim financial statements
5:18pm
6-K
EX-99.2
jta6n9h76qv11nzszh1
14 Aug 24
Condensed consolidated interim financial statements
6:13am
6-K
EX-99.1
jbdsv
14 Aug 24
Condensed consolidated interim financial statements
6:13am
6-K
EX-99.1
84d7d5yrig9 4i
9 Aug 24
Current report (foreign)
7:30am
6-K
EX-99.1
l6czxh
8 Jul 24
Annual General and Special Meeting of the Shareholders to Be Held on Management Information Circular
5:16pm
6-K
EX-99.1
bcoym5 e7q3nrqj32e
16 May 24
Current report (foreign)
8:01am
6-K
EX-99.2
h2jywti
15 May 24
Condensed consolidated interim financial statements
6:02am
6-K
EX-99.1
32dkxft8g4ciyxrez1o
15 May 24
Condensed consolidated interim financial statements
6:02am
6-K
EX-99.4
bzeedjzgw ba1vuc7a
15 May 24
Condensed consolidated interim financial statements
6:02am
6-K
EX-99.3
nnz24jx4xbef
15 May 24
Condensed consolidated interim financial statements
6:02am